Form 4: Interparfums Director Granted 1,500 Stock Options

Interparfums Inc. Director Patrick Bousquet Chavanne was granted 1,500 stock options with an exercise price of $84.64, vesting annually through 2030.

Summary

• Director Patrick Bousquet Chavanne of Interparfums Inc. (IPAR) was granted 1,500 stock options.
• The options have an exercise price of $84.64 per share.
• The grant occurred on December 31, 2025.
• The options vest in five annual tranches of 300 shares each, starting December 31, 2026, and concluding December 31, 2030.
• All options expire on December 30, 2031.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The grant of stock options to a director is a positive signal for aligning interests and retention, but it's a routine compensation event rather than a major strategic announcement. The future-dated transaction date is notable but not inherently negative.

Positives

• The grant of stock options to a director aligns management incentives with shareholder interests.
• The use of a Rule 10b5-1(c) plan indicates a pre-planned and transparent approach to insider transactions.

Negatives

• No immediate negative financial impact from an option grant itself.
• Potential future dilution if options are exercised, though this is standard for equity compensation.

Risks

• Future stock price performance below the exercise price of $84.64 would render the options worthless.
• Dilution of existing shareholder value if a significant number of options are exercised in the future.

Future Outlook

The grant of long-term stock options suggests a continued commitment by the director to the company's future performance and growth, aligning their financial interests with long-term shareholder value creation.

Industry Context

Equity compensation, particularly through stock options, is a common practice across industries to incentivize executives and directors, aligning their interests with long-term company performance and shareholder returns.

Comparison to Industry Standards

• The grant of stock options to directors is a standard practice in corporate governance across publicly traded companies, including those in the consumer discretionary and fragrance industries.
• The vesting schedule over several years is typical for long-term incentive plans, comparable to practices at companies like Estée Lauder (EL) or L'Oréal (OR.PA), which also use equity awards to retain and motivate key personnel.
• The exercise price being set at the market price on the grant date is standard for incentive stock options, ensuring that the options only gain value if the stock price appreciates.

Corporate Governance

Related Party Transactions

• The transaction involves the grant of stock options from Interparfums Inc. to its Director, Patrick Bousquet Chavanne, which is a standard related party compensation event.

Stakeholder Impact

• Shareholders: Potential for long-term value creation if the stock price appreciates, but also potential for minor dilution upon exercise.
• Management/Directors: Increased incentive and alignment with company performance.

Next Steps

• The director will monitor the company's stock performance relative to the $84.64 exercise price.
• Options will become exercisable in annual tranches from December 31, 2026, to December 31, 2030.
• The director may choose to exercise options upon vesting, subject to company policy and market conditions.

Key Dates

Recommendation

This filing reports a routine grant of stock options to a director, which is a standard compensation practice. It does not contain information that would fundamentally alter the investment thesis for Interparfums Inc. While it aligns director incentives, it's not a catalyst for a "buy" or "sell" recommendation. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

Interparfums, IPAR, Stock Options, Director Compensation, SEC Form 4, Insider Trading, Equity Grant, Rule 10b5-1